Ascendis Pharma A/S Income Statement

Income Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 20.04M27.10M18.59M9.02M5.10M1.73M12.50M14.80M8.29M8.90M52.21M286.97M393.58M
Cost of Revenue 4.03M12.38M47.77M47.90M
Gross Profit 14.80M8.29M4.87M39.83M239.21M345.68M
Operating items
Research & Development -14.63M-16.88M-26.18M45.02M73.09M112.47M165.72M212.10M311.07M338.46M387.31M444.85M332.28M
Selling, General & Administrative -3.46M-3.21M-8.34M10.46M12.74M15.23M29.60M53.65M91.41M183.24M225.71M284.49M315.11M
Operating Expenses -18.09M-20.09M-34.52M55.48M85.83M127.58M195.20M272.90M413.15M538.34M613.02M729.34M647.40M
Operating Income 1.95M7.01M-15.94M-46.46M-80.73M-125.97M-182.82M-250.95M-394.19M-516.84M-573.19M-490.13M-301.72M
EBIT 1.95M7.01M-15.94M-46.46M-80.73M-125.97M-182.82M-250.95M-394.19M-516.84M-573.19M-490.13M-301.72M
Non-operating items
Interest & Investment Income 0.01M0.21M2.50M12.27M8.08M1.04M29.20M19.71M2.16M68.32M53.24M47.19M27.72M
Net income details
EBT 1.65M6.25M-13.74M-37.29M-76.09M-140.46M-154.15M-241.58M-499.78M-439.22M-589.52M-510.15M-403.97M
Tax Provisions 0.05M0.83M-0.91M-0.72M-0.25M-0.54M-0.47M-0.26M-0.26M-0.42M5.49M7.86M5.24M
Profit After Tax 1.61M5.42M-12.84M-36.57M-75.84M-139.92M-153.69M-241.32M-499.52M-438.80M-595.00M-518.01M-409.21M
Equity Income -0.38M-8.98M-11.36M13.77M-18.06M-19.79M-21.71M
Income from Continuing Operations 1.61M5.42M-12.84M-36.57M-75.84M-139.92M-153.69M-241.32M-499.52M-438.80M-595.00M-518.01M-409.21M
Consolidated Net Income 1.61M5.42M-12.84M-36.57M-75.84M-139.92M-153.69M-241.32M-499.52M-438.80M-595.00M-518.01M-409.21M
Income towards Parent Company 1.61M5.42M-12.84M-36.57M-75.84M-139.92M-153.69M-241.32M-499.52M-438.80M-595.00M-518.01M-409.21M
Net Income towards Common Stockholders 1.61M5.42M-12.84M-36.57M-75.84M-139.92M-153.69M-241.32M-499.52M-438.80M-595.00M-518.01M-409.21M
Additional items
EPS (Basic) 0.23-0.54-1.54-2.86-4.16-3.74-5.19-9.87-8.01-10.61-9.20-7.07
EPS (Weighted Average and Diluted) 0.100.32-0.85-1.54-2.86-4.16-23.18-37.46-68.14-8.01-10.61-9.20-7.07
Shares Outstanding (Weighted Average) 23.84M23.84M25.13M25.21M36.37M42.03M47.74M52.72M53.83M57.03M57.66M57.54M
Shares Outstanding (Diluted Average) 15.50M17.03M15.16M26.40M4.09M5.22M6.63M6.44M7.33M8.11M7.00M7.02M
EBITDA 1.54M5.41M-12.86M-36.58M-75.83M-139.85M-153.67M-241.36M-499.57M-434.39M-595.34M-520.95M-408.07M
Interest Expenses -0.30M-0.97M0.30M3.11M3.45M15.54M0.15M1.35M96.39M4.47M51.51M47.41M108.26M
Tax Rate 2.72%13.30%6.60%1.94%0.33%0.38%0.30%0.11%0.05%0.10%